{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T10:11:46Z","timestamp":1794305506812,"version":"4.9.0"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2024,1,3]],"date-time":"2024-01-03T00:00:00Z","timestamp":1704240000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2024,1,3]],"date-time":"2024-01-03T00:00:00Z","timestamp":1704240000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Adv Ther"],"published-print":{"date-parts":[[2024,2]]},"DOI":"10.1007\/s12325-023-02749-x","type":"journal-article","created":{"date-parts":[[2024,1,3]],"date-time":"2024-01-03T10:02:16Z","timestamp":1704276136000},"page":"867-877","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["Oleogel-S10 in Dystrophic Epidermolysis Bullosa: A Case Series Evaluating the Impact on Wound Burden Over Two Years"],"prefix":"10.1007","volume":"41","author":[{"given":"Mauricio","family":"Torres Pradilla","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erick","family":"\u00c1lvarez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M\u00f3nica","family":"Novoa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ivonne","family":"Lozano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maribel","family":"Trujillo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,1,3]]},"reference":[{"issue":"1","key":"2749_CR1","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1038\/s41572-020-0210-0","volume":"6","author":"A Bardhan","year":"2020","unstructured":"Bardhan A, Bruckner-Tuderman L, et al. Epidermolysis bullosa. Nat Rev Dis Primers. 2020;6(1):78.","journal-title":"Nat Rev Dis Primers"},{"issue":"3","key":"2749_CR2","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1016\/j.jaad.2009.03.052","volume":"61","author":"JD Fine","year":"2009","unstructured":"Fine JD, Mellerio JE. Extracutaneous manifestations and complications of inherited epidermolysis bullosa: part I. Epithelial associated tissues. J Am Acad Dermatol. 2009;61(3):367\u201384.","journal-title":"J Am Acad Dermatol"},{"issue":"3","key":"2749_CR3","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1016\/j.jaad.2009.03.053","volume":"61","author":"JD Fine","year":"2009","unstructured":"Fine JD, Mellerio JE. Extracutaneous manifestations and complications of inherited epidermolysis bullosa: part II Other organs. J Am Acad Dermatol. 2009;61(3):387\u2013402.","journal-title":"J Am Acad Dermatol"},{"issue":"7","key":"2749_CR4","doi-asserted-by":"publisher","first-page":"1731","DOI":"10.1007\/s11136-020-02495-5","volume":"29","author":"CCG Togo","year":"2021","unstructured":"Togo CCG, Zidorio APC, Gon\u00e7alves VSS, Hubbard L, de Carvalho KMB, Dutra ES. Quality of life in people with epidermolysis bullosa: a systematic review. Qual Life Res. 2021;29(7):1731\u201345.","journal-title":"Qual Life Res"},{"key":"2749_CR5","unstructured":"Denyer J, Pillay E, Clapham J. Best practice guidelines for skin and wound care in epidermolysis bullosa. An International Consensus. Wounds International; 2017. Available at: https:\/\/www.woundsinternational.com\/resources\/details\/best-practice-guidelines-skin-and-wound-care-in-epidermolysis-bullosa."},{"key":"2749_CR6","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1016\/j.abd.2021.09.010","volume":"97","author":"D Miyamoto","year":"2022","unstructured":"Miyamoto D, Gordilho JO, Santi CG, Porro AM. Epidermolysis bullosa acquisita. An Bras Dermatol. 2022;97:409\u201323.","journal-title":"An Bras Dermatol"},{"issue":"15","key":"2749_CR7","doi-asserted-by":"publisher","first-page":"1389","DOI":"10.1055\/s-2006-951723","volume":"72","author":"M Laszczyk","year":"2006","unstructured":"Laszczyk M, J\u00e4ger S, Simon-Haarhaus B, Scheffler A, Schempp CM. Physical, chemical and pharmacological characterization of a new oleogel-forming triterpene extract from the outer bark of birch (betulae cortex). Planta Med. 2006;72(15):1389\u201395.","journal-title":"Planta Med"},{"key":"2749_CR8","doi-asserted-by":"publisher","first-page":"5068969","DOI":"10.1155\/2017\/5068969","volume":"2017","author":"A Schwieger-Briel","year":"2017","unstructured":"Schwieger-Briel A, Kiritsi D, Schempp C, Has C, Schumann H. Betulin-based oleogel to improve wound healing in dystrophic epidermolysis bullosa: a prospective controlled proof-of-concept study. Dermatol Res Pract. 2017;2017:5068969.","journal-title":"Dermatol Res Pract"},{"issue":"4","key":"2749_CR9","first-page":"12983","volume":"32","author":"A Schwieger-Briel","year":"2019","unstructured":"Schwieger-Briel A, Ott H, Kiritsi D, Laszczyk-Lauer M, Bodemer C. Mechanism of Oleogel-S10: a triterpene preparation for the treatment of epidermolysis bullosa. Dermatol Ther. 2019;32(4):12983.","journal-title":"Dermatol Ther"},{"issue":"1","key":"2749_CR10","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1093\/bjd\/ljac001","volume":"188","author":"JS Kern","year":"2023","unstructured":"Kern JS, Sprecher E, Fernandez MF, et al. Efficacy and safety of Oleogel-S10 (birch triterpenes) for epidermolysis bullosa: results from the phase III randomized double-blind phase of the EASE study. Br J Dermatol. 2023;188(1):12\u201321.","journal-title":"Br J Dermatol"},{"key":"2749_CR11","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1111\/jdv.13953","volume":"31","author":"SV Jain","year":"2017","unstructured":"Jain SV, Harris AG, Su JC, et al. The Epidermolysis Bullosa Disease Activity and Scarring Index (EBDASI): grading disease severity and assessing responsiveness to clinical change in epidermolysis bullosa. J Eur Acad Dermatol Venereol. 2017;31:692\u20138.","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"1","key":"2749_CR12","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.jaad.2013.09.041","volume":"70","author":"C Loh","year":"2014","unstructured":"Loh C, Kim J, Su J, et al. Development, reliability, and validity of a novel Epidermolysis Bullosa Disease Activity and Scarring Index (EBDASI). J Am Acad Dermatol. 2014;70(1):89\u201397.","journal-title":"J Am Acad Dermatol"},{"key":"2749_CR13","first-page":"224","volume":"11","author":"JE Mellerio","year":"2023","unstructured":"Mellerio JE, Kiritsi D, Marinkovich MP, et al. Mapping the burden of severe forms of epidermolysis bullosa\u2014implications for patient management. J Am Acad Dermatol Int. 2023;11:224\u201332.","journal-title":"J Am Acad Dermatol Int"},{"issue":"1","key":"2749_CR14","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13023-019-1279-y","volume":"15","author":"AL Bruckner","year":"2023","unstructured":"Bruckner AL, Losow M, Wisk J, et al. The challenges of living with and managing epidermolysis bullosa: insights from patients and caregivers. Orphanet J Rare Dis. 2023;15(1):1.","journal-title":"Orphanet J Rare Dis"},{"issue":"Suppl 4","key":"2749_CR15","first-page":"ljad113","volume":"188","author":"D Murrell","year":"2023","unstructured":"Murrell D, Bruckner AL, Sprecher E, et al. BG04 Oleogel-S10 (birch triterpenes) in the treatment of epidermolysis bullosa wounds: 24-month efficacy and safety data from the EASE study. Br J Dermatol. 2023;188(Suppl 4):ljad113-144.","journal-title":"Br J Dermatol"},{"key":"2749_CR16","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1186\/s12916-014-0178-2","volume":"12","author":"KR Goldschneider","year":"2014","unstructured":"Goldschneider KR, Good J, Harrop E, et al. Pain care for patients with epidermolysis bullosa: best care practice guidelines. BMC Med. 2014;12:178.","journal-title":"BMC Med"},{"key":"2749_CR17","first-page":"20","volume":"2","author":"ML Bageta","year":"2021","unstructured":"Bageta ML, Yerlett N, McGrath JA, et al. The natural history of severe recessive dystrophic epidermolysis bullosa\u20144 phases which may help determine different therapeutic approaches. J Dermatol Venereol. 2021;2:20\u20131.","journal-title":"J Dermatol Venereol"},{"issue":"2","key":"2749_CR18","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1016\/j.det.2010.01.002","volume":"28","author":"JE Denyer","year":"2010","unstructured":"Denyer JE. Wound management for children with epidermolysis bullosa. Dermatol Clin. 2010;28(2):257\u201364.","journal-title":"Dermatol Clin"},{"key":"2749_CR19","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1186\/s13023-020-01443-3","volume":"15","author":"C Prodinger","year":"2020","unstructured":"Prodinger C, Diem A, Ude-Schoder K, et al. Profiling trial burden and patients\u2019 attitudes to improve clinical research in epidermolysis bullosa. Orphanet J Rare Dis. 2020;15:182.","journal-title":"Orphanet J Rare Dis"},{"issue":"3","key":"2749_CR20","doi-asserted-by":"publisher","first-page":"182","DOI":"10.2174\/1573396317666210525161252","volume":"18","author":"KL Hon","year":"2022","unstructured":"Hon KL, Chu S, Leung AK. Epidermolysis bullosa: pediatric perspectives. Curr Pediatr Rev. 2022;18(3):182\u201390.","journal-title":"Curr Pediatr Rev"},{"issue":"12","key":"2749_CR21","doi-asserted-by":"publisher","first-page":"7059","DOI":"10.3390\/ijerph19127059","volume":"19","author":"AR Villar Hern\u00e1ndez","year":"2022","unstructured":"Villar Hern\u00e1ndez AR, Molero Alonso F, Aguado Mar\u00edn \u00c1J, Posada-de-la-Paz M. Transcultural validation of a Spanish version of the quality of life in epidermolysis bullosa questionnaire. Int J Environ Res Public Health. 2022;19(12):7059.","journal-title":"Int J Environ Res Public Health"}],"updated-by":[{"DOI":"10.1007\/s12325-024-03040-3","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2024,12,5]],"date-time":"2024-12-05T00:00:00Z","timestamp":1733356800000}}],"container-title":["Advances in Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12325-023-02749-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12325-023-02749-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12325-023-02749-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,6]],"date-time":"2024-12-06T07:16:34Z","timestamp":1733469394000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12325-023-02749-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1,3]]},"references-count":21,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2024,2]]}},"alternative-id":["2749"],"URL":"https:\/\/doi.org\/10.1007\/s12325-023-02749-x","relation":{"correction":[{"id-type":"doi","id":"10.1007\/s12325-024-03040-3","asserted-by":"object"}]},"ISSN":["0741-238X","1865-8652"],"issn-type":[{"value":"0741-238X","type":"print"},{"value":"1865-8652","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,1,3]]},"assertion":[{"value":"22 September 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 November 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 January 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 December 2024","order":4,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":5,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1007\/s12325-024-03040-3","URL":"https:\/\/doi.org\/10.1007\/s12325-024-03040-3","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Mauricio Torres Pradilla has received honoraria or research grants from AbbVie, Amryt Pharma, Avicanna Inc., Eucerin, Galderma, Gencell Pharma, Novartis, Pfizer, Pierre Fabre, Roemmers, Sanofi, Uno Healthcare. All other authors (Erick \u00c1lvarez, M\u00f3nica Novoa, Ivonne Lozano and Maribel Trujillo) have no disclosures to report.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"Institutional review board approval was not required for this retrospective case series, but all data were collected in accordance with the Helsinki Declaration of 1964 and its later amendments. All patients or their representatives provided written consent for their clinical data and photos to be published.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}}]}}